Evidence map›Paper›PMID 33268815›Full record

ArticleScientific reports2020

A proof of concept 'phase zero' study of neurodevelopment using brain organoid models with Vis/near-infrared spectroscopy and electrophysiology.

Anirban Dutta, Sneha Sudhakar Karanth, Mahasweta Bhattacharya, Michal Liput, Justyna Augustyniak, Mancheung Cheung, Ewa K Stachowiak, Michal K Stachowiak

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Schizophrenia: from mechanism to therapy.Science China. Life sciences · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Anirban DuttaDepartment of Biomedical Engineering, University at Buffalo, Buffalo, 14260, USA. adutta@case.edu.
Sneha Sudhakar KaranthDepartment of Biomedical Engineering, University at Buffalo, Buffalo, 14260, USA.
Mahasweta BhattacharyaDepartment of Biomedical Engineering, University at Buffalo, Buffalo, 14260, USA.
Michal LiputDepartment of Pathology and Anatomical Sciences, University at Buffalo, Buffalo, 14260, USA.
Justyna AugustyniakDepartment of Pathology and Anatomical Sciences, University at Buffalo, Buffalo, 14260, USA.
Mancheung CheungDepartment of Biomedical Engineering, University at Buffalo, Buffalo, 14260, USA.
Ewa K StachowiakDepartment of Pathology and Anatomical Sciences, University at Buffalo, Buffalo, 14260, USA.
Michal K StachowiakDepartment of Biomedical Engineering, University at Buffalo, Buffalo, 14260, USA. mks4@buffalo.edu.
University at Buffalo, State University of New York · USPolish Academy of Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Homeostatic control of neuronal excitability by modulation of synaptic inhibition (I) and excitation (E) of the principal neurons is important during brain maturation. The fundamental features of in-utero brain development, including local synaptic E-I ratio and bioenergetics, can be modeled by cerebral organoids (CO) that have exhibited highly regular nested oscillatory network events. Therefore, we evaluated a 'Phase Zero' clinical study platform combining broadband Vis/near-infrared(NIR) spectroscopy and electrophysiology with studying E-I ratio based on the spectral exponent of local field potentials and bioenergetics based on the activity of mitochondrial Cytochrome-C Oxidase (CCO). We found a significant effect of the age of the healthy controls iPSC CO from 23 days to 3 months on the CCO activity (chi-square (2, N = 10) = 20, p = 4.5400e-05), and spectral exponent between 30-50 Hz (chi-square (2, N = 16) = 13.88, p = 0.001). Also, a significant effect of drugs, choline (CHO), idebenone (IDB), R-alpha-lipoic acid plus acetyl-L-carnitine (LCLA), was found on the CCO activity (chi-square (3, N = 10) = 25.44, p = 1.2492e-05), spectral exponent between 1 and 20 Hz (chi-square (3, N = 16) = 43.5, p = 1.9273e-09) and 30-50 Hz (chi-square (3, N = 16) = 23.47, p = 3.2148e-05) in 34 days old CO from schizophrenia (SCZ) patients iPSC. We present the feasibility of a multimodal approach, combining electrophysiology and broadband Vis-NIR spectroscopy, to monitor neurodevelopment in brain organoid models that can complement traditional drug design approaches to test clinically meaningful hypotheses.

Indexed as

AcetylcarnitineBrainCase-Control StudiesCell LineCholineElectron Transport Complex IVElectrophysiologyFemaleHumansInduced Pluripotent Stem CellsMaleMitochondriaOrganoidsProof of Concept StudySchizophreniaSpectroscopy, Near-InfraredAcetylcarnitineCholineElectron Transport Complex IVidebenoneThioctic AcidUbiquinone

Identifiers

PMID33268815
PMCPMC7710726
OpenAlexW3106673212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.